Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax.

White MT, Walker P, Karl S, Hetzel MW, Freeman T, Waltmann A, Laman M, Robinson LJ, Ghani A, Mueller I.

Nat Commun. 2018 Aug 17;9(1):3300. doi: 10.1038/s41467-018-05860-8.

PMID:
30120250
2.

Diversity pattern of Duffy binding protein sequence among Duffy-negatives and Duffy-positives in Sudan.

Hoque MR, Elfaki MMA, Ahmed MA, Lee SK, Muh F, Ali Albsheer MM, Hamid MMA, Han ET.

Malar J. 2018 Aug 17;17(1):297. doi: 10.1186/s12936-018-2425-z.

PMID:
30119671
3.

Exflagellation of Plasmodium vivax microgametocytes in human peripheral blood.

Singh Bhar V, Agarwal M.

Blood. 2018 Aug 16;132(7):767. doi: 10.1182/blood-2018-01-828913. No abstract available.

PMID:
30115637
4.

Unraveling the Plasmodium vivax sporozoite transcriptional journey from mosquito vector to human host.

Roth A, Adapa SR, Zhang M, Liao X, Saxena V, Goffe R, Li S, Ubalee R, Saggu GS, Pala ZR, Garg S, Davidson S, Jiang RHY, Adams JH.

Sci Rep. 2018 Aug 15;8(1):12183. doi: 10.1038/s41598-018-30713-1.

5.

Malaria control and chemoprophylaxis policy in the Republic of Korea Armed Forces for the previous 20 years (1997-2016).

Im JH, Huh K, Yoon CG, Woo H, Lee JS, Chung MH, Klein TA, Jung J.

Malar J. 2018 Aug 15;17(1):295. doi: 10.1186/s12936-018-2449-4.

6.

HIV and Malaria Infections and Associated Risk Factors Among Febrile Illness Patients in Northwest Ethiopia.

Wondimeneh Y, Gebrecherkos T, Muluye D, Damtie D, Ferede G.

Turkiye Parazitol Derg. 2018 Aug 15. doi: 10.5152/tpd.2018.5878. [Epub ahead of print]

PMID:
30109850
7.

Structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase-dihydropteroate synthase from Plasmodium vivax sheds light on drug resistance.

Yogavel M, Nettleship JE, Sharma A, Harlos K, Jamwal A, Chaturvedi R, Sharma M, Jain V, Chhibber-Goel J, Sharma A.

J Biol Chem. 2018 Aug 13. pii: jbc.RA118.004558. doi: 10.1074/jbc.RA118.004558. [Epub ahead of print]

8.

Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.

Avula B, Tekwani BL, Chaurasiya ND, Fasinu P, Dhammika Nanayakkara NP, Bhandara Herath HMT, Wang YH, Bae JY, Khan SI, Elsohly MA, McChesney JD, Zimmerman PA, Khan IA, Walker LA.

Malar J. 2018 Aug 13;17(1):294. doi: 10.1186/s12936-018-2433-z.

9.

Vivax infection alters peripheral B cell profile and induces persistent serum IgM.

Patgaonkar M, Herbert F, Powale K, Gandhe P, Gogtay N, Thatte U, Pied S, Sharma S, Pathak S.

Parasite Immunol. 2018 Aug 13:e12580. doi: 10.1111/pim.12580. [Epub ahead of print]

PMID:
30102786
10.

Therapeutic and Transmission-Blocking 
Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia.

Popovici J, Vantaux A, Primault L, Samreth R, Piv EP, Bin S, Kim S, Lek D, Serre D, Menard D.

Emerg Infect Dis. 2018 Aug;24(8):1516-1519. doi: 10.3201/eid2408.170768. Epub 2018 Aug 17.

Supplemental Content

Loading ...
Support Center